---
figid: PMC8830521__fphar-13-803717-g006
figtitle: Apoptosis Induction, a Sharp Edge of Berberine to Exert Anti-Cancer Effects,
  Focus on Breast, Lung, and Liver Cancer
organisms:
- herbal medicine
- Coptis chinensis
- Fagopyrum tataricum
- Coptis japonica
- Berberis vulgaris
- Hydrastis canadensis
- Phellodendron amurense
- Phellodendron chinense
- Chelidonium majus
- Berberis aristata
- Berberis bealei
- Berberis aquifolium
- Coptis teeta
- Berberis asiatica
- Berberis thunbergii
- Berberis koreana
- Berberis aetnensis
- Arcangelisia flava
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Danio rerio
- gut metagenome
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Danio rerio
- Drosophila melanogaster
pmcid: PMC8830521
filename: fphar-13-803717-g006.jpg
figlink: /pmc/articles/PMC8830521/figure/F6/
number: F6
caption: The pro-apoptotic mechanisms of BBR in liver cancer. BBR promotes apoptosis
  by suppressing the expression of SLC1A5 and c-MYC (; ). BBR increases the expression
  of CDKIs p21Cip1 and p27Kip1 via regulating the AKT/FoxO3a signaling pathway ().
  Likewise, BBR induces apoptosis through iPLA2/LOX-5/LTB4 pathway and PHLPP2-AKT-MST1
  axis (; ). Besides, BBR inhibits cell proliferation through ERK1/2 and GPT1 axis
  (; ). BBR can regulate adenylate cyclase signaling in association with MKK3/6 stabilization
  to exert necroptosis (). BBR upregulates miR-22-3p to inhibit cell proliferation
  (). Furthermore, BBR simultaneously inhibits NF-κB p65 and β-catenin translation
  to promote apoptosis (). The apoptosis promotion of BBR may also be related to the
  inhibition of PI3K/AKT, p38 MAPK/ERK-COX2 and HIF-1α (; ; ).
papertitle: Apoptosis Induction, a Sharp Edge of Berberine to Exert Anti-Cancer Effects,
  Focus on Breast, Lung, and Liver Cancer.
reftext: Yi Zhu, et al. Front Pharmacol. 2022;13:803717.
year: '2022'
doi: 10.3389/fphar.2022.803717
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: berberine | bioavailability | ADMET | anticancer effects | apoptosis induction
automl_pathway: 0.8696265
figid_alias: PMC8830521__F6
figtype: Figure
redirect_from: /figures/PMC8830521__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8830521__fphar-13-803717-g006.html
  '@type': Dataset
  description: The pro-apoptotic mechanisms of BBR in liver cancer. BBR promotes apoptosis
    by suppressing the expression of SLC1A5 and c-MYC (; ). BBR increases the expression
    of CDKIs p21Cip1 and p27Kip1 via regulating the AKT/FoxO3a signaling pathway ().
    Likewise, BBR induces apoptosis through iPLA2/LOX-5/LTB4 pathway and PHLPP2-AKT-MST1
    axis (; ). Besides, BBR inhibits cell proliferation through ERK1/2 and GPT1 axis
    (; ). BBR can regulate adenylate cyclase signaling in association with MKK3/6
    stabilization to exert necroptosis (). BBR upregulates miR-22-3p to inhibit cell
    proliferation (). Furthermore, BBR simultaneously inhibits NF-κB p65 and β-catenin
    translation to promote apoptosis (). The apoptosis promotion of BBR may also be
    related to the inhibition of PI3K/AKT, p38 MAPK/ERK-COX2 and HIF-1α (; ; ).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Ctnnb1
  - Smo
  - Smox
  - Mycn
  - Mdk
  - Ephb2
  - Mapk1
  - Myc
  - Nol3
  - Shc3
  - Ksr1
  - Map3k5
  - Dbf4
  - Arsk
  - Zhx2
  - tor
  - Rorc
  - Pik3r1
  - Akt1
  - Phlpp2
  - COX2
  - Ptgs2
  - Cdkn1b
  - Dctn6
  - Psmd9
  - Cdkn1a
  - Nsg1
  - Tpt1
  - Tceal1
  - Casp3
  - Pla2g6
  - CTNNB1
  - SMO
  - SMOX
  - MYCN
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - MYC
  - GDF1
  - RNH1
  - PPP1R13L
  - SHC3
  - KSR1
  - KSR2
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - DBF4
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - RORC
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - PHLPP2
  - PTGS2
  - MTCO2P12
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - PLA2G6
  - ATP8A2
  - Ephb1
  - Pik3cg
  - Tmed7
  - Kras
  - ctnnb1
  - smo
  - rpl36a
  - mycn
  - myca
  - mycbp2
  - mtor
  - phlpp2
  - cdkn1a
  - arm
  - sm
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - rai
  - ksr
  - MKP-4
  - p38b
  - Raf
  - Tor
  - Egfr
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - ppk
  - Akt
  - DCTN6-p27
  - dap
  - CG9588
  - Decay
  - ATPsynbeta
  - Atpalpha
---
